El Vínculo El Vínculo.
MałopolskieNowosądecki
Awarded European Union Supplies

Dostawy produktów leczniczych

Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Awarded to CSL Behring Spółka z o.o. and 7 others. Estimated value: 5,037,283 zł.

Interested in tenders like this? Get the next tenders like this one published in the European Union by email. Free, no card needed.

Amounts and figures

5,037,283 zł
Estimated value
17
Lots
2
Bids received

Description

Przedmiot zamówienia obejmuje 18 części : Część nr 1: Interferon β-1a Część nr 2: Glatirameru octan Część nr 3: Fumaran dimetylu Część nr 4: Peginterferon-β-1a Część nr 5: Teryflunomid Część nr 6: Ofatumumab Część nr 7: Ozanimod Część nr 8: Ponesimod Część nr 9: Siponimod Część nr 10: Fingolimod Część nr 11: Natalizumab Część nr 12: Okrelizumab Część nr 13: Kladrybina Część nr 14: Alemtuzumabum Część nr 15: Interferon β- 1a Część nr 16: Interferon β- 1b Część nr 17: Immunoglobuliny Część nr 18: Immunoglobuliny

Lots (17)

LotDescriptionCPV codeAmount
1 Część nr 1: Interferon β-1a 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
2 Część nr 2: Glatirameru octan 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
3 Część nr 3: Fumaran dimetylu 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
4 Część nr 4: Peginterferon-β-1a 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
5 Część nr 5: Teryflunomid 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
6 Część nr 6: Ofatumumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
7 Część nr 7: Ozanimod 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
8 Część nr 8: Ponesimod 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
9 Część nr 9: Siponimod 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
10 Część nr 10: Fingolimod 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
11 Część nr 11: Natalizumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
12 Część nr 12: Okrelizumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
13 Część nr 13: Kladrybina 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
14 Część nr 14: Alemtuzumabum 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
15 Część nr 15: Interferon β- 1a 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
16 Część nr 16: Interferon β- 1b 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
17 Część nr 18: Immunoglobuliny 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —

Award criteria

TypeCriterionWeight
Pricecena—

Awards

LotAwarded toAmountBids receivedDate
2
Część nr 2: Glatirameru octan
ASCLEPIOS S.A. (Część 12) 88,890 zł 1 29 July 2024
3
Część nr 3: Fumaran dimetylu
Farmacol Logistyka Sp. z o. o. (Cześć 1) 869,588 zł 1 29 July 2024
4
Część nr 4: Peginterferon-β-1a
Farmacol Logistyka Sp. z o. o. (Cześć 1) 68,647 zł 1 29 July 2024
6
Część nr 6: Ofatumumab
Farmacol Logistyka Sp. z o. o. (Cześć 1) 290,136 zł 1 29 July 2024
11
Część nr 11: Natalizumab
Farmacol Logistyka Sp. z o. o. (Cześć 1) 299,581 zł 1 29 July 2024
12
Część nr 12: Okrelizumab
Roche Polska Sp. z o. o. (Część 9) 837,167 zł 1 29 July 2024
13
Część nr 13: Kladrybina
Centrala Farmaceutyczna Cefarm S.A. 152,356 zł 2 29 July 2024
14
Część nr 14: Alemtuzumabum
Sanofi-Aventis Sp. z o.o. (Część 10) 112,222 zł 1 29 July 2024
16
Część nr 16: Interferon β- 1b
URTICA Sp. z. o. o. (część 8,11,13,14,17) 110,640 zł 2 29 July 2024
17
Część nr 18: Immunoglobuliny
CSL Behring Spółka z o.o. 1,044,575 zł 1 29 July 2024

Official publications

MediumReferenceDate
TED 487208-2024 13 August 2024
OJS 157/2024 13 August 2024

Other tenders from Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Previous and next from Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Similar open tenders

Frequently asked questions

What is the estimated value of this tender?
The estimated value published by the buyer is 5,037,283 zł.
Who is the buyer of this tender?
The contracting authority is Szpital Specjalistyczny im. Jędrzeja Śniadeckiego (European Union).
How can I bid for public tenders in the European Union?
Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.

How can I find out about similar tenders when they are published?

Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders like this one come out in the European Union. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.

No credit card · Sign up in 2 minutes.

Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.